Combinostics is a cloud platform for quantitative assessment of brain images and for providing clinical decision support in neurological disorders. As there are no effective treatments for neurodegenerative diseases like Alzheimer’s, early-stage diagnosis combined with symptomatic treatment and lifestyle intervention can make a drastic difference to quality of life in later years. Combinostic SaaS-solution, cNeuro, is a data driven clinical decision support tool that fits the workflow of radiologists and neurologists or other healthcare professionals detecting neurodegenerative disorders. Combinostics software helps healthcare professionals make an early diagnosis of neurodegenerative diseases and gives them an overview of all patient data and highlights relationships that affect how readings are interpreted. Early detection can help patients significantly delay disease progression, giving them opportunities to live longer, fuller lives through symptomatic treatment and prevention interventions.


Combinostics at glance

  • What they do: A software to support healthcare professionals in early-stage neurodegenerative diagnosis.
  • Founded in: 2014
  • Headquarters: Tampere, Finland

By continuing to interact with the site, you agree to the use of cookies. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.